Similarly, the wound healing assay and the transwell assay showed that the knocking down of G9a led to obvious reduction in renal cancer cell migration and invasion, which was consistent with G9a inhibitor treatment (Figures 4(e) and 4(f)). This evidence concerns the gene EHMT2 and renal carcinoma.